Analysis of Pfizer vaccine effect in Israel - Printable Version +- theCOVIDboard (https://thecovidboard.createmybb4.com) +-- Forum: COVID-19 (https://thecovidboard.createmybb4.com/forum-1.html) +--- Forum: Research (https://thecovidboard.createmybb4.com/forum-4.html) +--- Thread: Analysis of Pfizer vaccine effect in Israel (/thread-102.html) |
||||||||||||||||||
Analysis of Pfizer vaccine effect in Israel - M_T - 03-01-2021 Feb. 24 NEJM article:Â "BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting" This is an analysis of data from Israel based on evaluating the data being collected from the nationwide vaccinations. Â Records of those without vaccines were paired with those who got vaccines with as much similarity as possible. Lots of good info here. Â Look well done to me. Â Data up to Feb. 1. Â The UK variant was common at the end of data collection. (80%) but the South African variant wasn't. The article estimates the Pfizer vaccine effectiveness at reducing various outcomes
Effectiveness for reducing documented infections or symptomatic COVID-19 was consistent across age groups. The Pfizer vaccine appeared effective at reducing infections from the UK variant. |